Cipher Pharmaceuticals Statistics

Total Valuation

Cipher Pharmaceuticals has a market cap or net worth of CAD 376.68 million. The enterprise value is 418.86 million.

Market Cap	376.68M
Enterprise Value	418.86M

Important Dates

The last earnings date was Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Cipher Pharmaceuticals has 25.59 million shares outstanding. The number of shares has decreased by -2.82% in one year.

Current Share Class	n/a
Shares Outstanding	25.59M
Shares Change (YoY)	-2.82%
Shares Change (QoQ)	+4.58%
Owned by Insiders (%)	43.36%
Owned by Institutions (%)	1.38%
Float	14.49M

Valuation Ratios

The trailing PE ratio is 17.22 and the forward PE ratio is 14.33.

PE Ratio	17.22
Forward PE	14.33
PS Ratio	10.04
PB Ratio	2.82
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.49, with an EV/FCF ratio of -4.63.

EV / Earnings	19.55
EV / Sales	11.72
EV / EBITDA	24.49
EV / EBIT	31.37
EV / FCF	-4.63

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.41.

Current Ratio	2.00
Quick Ratio	1.57
Debt / Equity	0.41
Debt / EBITDA	3.22
Debt / FCF	-0.61
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 17.98% and return on invested capital (ROIC) is 5.68%.

Return on Equity (ROE)	17.98%
Return on Assets (ROA)	5.06%
Return on Capital (ROIC)	5.68%
Revenue Per Employee	7.15M
Profits Per Employee	4.28M
Employee Count	5
Asset Turnover	0.22
Inventory Turnover	1.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +169.10% in the last 52 weeks. The beta is 1.20, so Cipher Pharmaceuticals's price volatility has been higher than the market average.

Beta (5Y)	1.20
52-Week Price Change	+169.10%
50-Day Moving Average	15.42
200-Day Moving Average	11.14
Relative Strength Index (RSI)	49.16
Average Volume (20 Days)	67,115

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cipher Pharmaceuticals had revenue of CAD 35.75 million and earned 21.42 million in profits. Earnings per share was 0.85.

Revenue	35.75M
Gross Profit	28.88M
Operating Income	13.35M
Pretax Income	12.82M
Net Income	21.42M
EBITDA	16.99M
EBIT	13.35M
Earnings Per Share (EPS)	0.85

Full Income Statement

Balance Sheet

The company has 12.87 million in cash and 55.05 million in debt, giving a net cash position of -42.19 million or -1.65 per share.

Cash & Cash Equivalents	12.87M
Total Debt	55.05M
Net Cash	-42.19M
Net Cash Per Share	-1.65
Equity (Book Value)	133.55M
Book Value Per Share	5.22
Working Capital	19.66M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.67 million and capital expenditures -108.15 million, giving a free cash flow of -90.49 million.

Operating Cash Flow	17.67M
Capital Expenditures	-108.15M
Free Cash Flow	-90.49M
FCF Per Share	-3.54

Full Cash Flow Statement

Margins

Gross margin is 80.78%, with operating and profit margins of 37.35% and 59.92%.

Gross Margin	80.78%
Operating Margin	37.35%
Pretax Margin	35.86%
Profit Margin	59.92%
EBITDA Margin	47.52%
EBIT Margin	37.35%
FCF Margin	-253.13%

Dividends & Yields

Cipher Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.82%
Shareholder Yield	2.82%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cipher Pharmaceuticals has an Altman Z-Score of 2.86. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.86
Piotroski F-Score	n/a